COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin

BACKGROUND: Some studies have found worse prognosis among COX-2 expressing breast cancers. Aspirin and NSAIDs inhibit COX-2. Three studies, including ours, have reported a survival advantage among women with breast cancer who take either aspirin or NSAIDs. We hypothesized that in the Nurses’ Health...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Holmes, Michelle D., Chen, Wendy Y., Schnitt, Stuart J., Collins, Laura, Colditz, Graham A., Hankinson, Susan E., Tamimi, Rulla M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3292350/
https://ncbi.nlm.nih.gov/pubmed/21728052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-011-1651-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky